---
title: "New Stock Listing | MICOT PHARMA rose 100% and SEER TECH rose 4%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290666470.md"
description: "MICOT PHARMA and SEER TECH both saw their stock prices rise on their first day of listing. MICOT PHARMA closed at HKD 36.9, an increase of 1.03 times the offering price; SEER TECH closed at HKD 106, up 4.3%. The net fundraising amounts for the two companies were approximately HKD 989 million and HKD 995 million, respectively, with both public offerings significantly oversubscribed"
datetime: "2026-06-24T08:40:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290666470.md)
  - [en](https://longbridge.com/en/news/290666470.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290666470.md)
---

# New Stock Listing | MICOT PHARMA rose 100% and SEER TECH rose 4%

Two new stocks listed on their first day, both closing higher.

Biotechnology company MICOT PHARMA ( 02335) reached a high of HKD 37.1, up 1.04 times from the offering price of HKD 18.2, closing at HKD 36.9, up 1.03 times. One lot of 200 shares yields a profit of HKD 3,740.

Intelligent robotics company SEER TECH ( 06106) reached a high of HKD 140.5, up 38.3% from the offering price of HKD 101.6, closing at HKD 106, up 4.3%. One lot of 20 shares yields a profit of HKD 220.

MICOT PHARMA raised a net amount of HKD 989 million. The public offering was oversubscribed 1,180 times, with a winning rate of 3% for one lot. SEER TECH raised a net amount of HKD 995 million. The public offering was oversubscribed 5,933 times, with a winning rate of 5%

### Related Stocks

- [02335.HK](https://longbridge.com/en/quote/02335.HK.md)
- [06106.HK](https://longbridge.com/en/quote/06106.HK.md)

## Related News & Research

- [CMB International leads XianGong Intelligent HK$ 1.07 billion Hong Kong IPO](https://longbridge.com/en/news/290654311.md)
- [Seer Robotics rides 24-hour market swing in Hong Kong debut](https://longbridge.com/en/news/290804793.md)
- [Everest Medicines enters China commercialization collaboration with Hainan Herui for budesonide enteric capsules](https://longbridge.com/en/news/290642767.md)
- [The AI Boom Is Entering A New Phase -- And Nvidia May Not Be The Biggest Winner](https://longbridge.com/en/news/290419546.md)
- [Asymchem Aligns H Share Register Closure for Dividend and Shareholder Meetings](https://longbridge.com/en/news/290807877.md)